| Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2 JP Gérard, D Azria, S Gourgou-Bourgade, I Martel-Laffay, C Hennequin, ... Journal of clinical oncology 28 (10), 1638-1644, 2010 | 960 | 2010 |
| Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer JP Gérard, D Azria, S Gourgou-Bourgade, I Martel-Lafay, C Hennequin, ... Journal of clinical oncology 30 (36), 4558-4565, 2012 | 487 | 2012 |
| Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial D Peiffert, L Tournier-Rangeard, JP Gérard, C Lemanski, E François, ... Journal of clinical oncology 30 (16), 1941-1948, 2012 | 379 | 2012 |
| Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature D Cowen, P Richaud, F Mornex, T Bachelot, GM Jung, X Mirabel, ... Radiotherapy and Oncology 34 (1), 9-16, 1995 | 171 | 1995 |
| Radiotherapy alone for primary Merkel cell carcinoma L Mortier, X Mirabel, C Fournier, F Piette, E Lartigau Archives of dermatology 139 (12), 1587-1590, 2003 | 160 | 2003 |
| Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa C Lavogiez, E Delaporte, S Darras-Vercambre, E Martin De Lassalle, ... Dermatology 220 (2), 147-153, 2010 | 153 | 2010 |
| Radiotherapy and chemotherapy for invasive thymomas: a multicentric retrospective review of 90 cases. The FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le … F Mornex, M Resbeut, P Richaud, GM Jung, X Mirabel, C Marchal, ... International journal of radiation oncology, biology, physics 32 (3), 651-659, 1995 | 148 | 1995 |
| Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results C Louis, S Dewas, X Mirabel, T Lacornerie, A Adenis, F Bonodeau, ... Technology in cancer research & treatment 9 (5), 479-487, 2010 | 141 | 2010 |
| Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity JE Bibault, S Dewas, C Vautravers-Dewas, A Hollebecque, H Jarraya, ... PloS one 8 (10), e77472, 2013 | 126 | 2013 |
| Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? C Vautravers-Dewas, S Dewas, F Bonodeau, A Adenis, T Lacornerie, ... International Journal of Radiation Oncology* Biology* Physics 81 (3), e39-e47, 2011 | 114 | 2011 |
| Primary mucosal melanoma of head and neck: prognostic value of clear margins N Penel, Y Mallet, X Mirabel, JT Van, JL Lefebvre The Laryngoscope 116 (6), 993-995, 2006 | 112 | 2006 |
| Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study G Piessen, M Messager, X Mirabel, N Briez, WB Robb, A Adenis, ... Annals of surgery 258 (5), 793-800, 2013 | 103 | 2013 |
| High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer … D Peiffert, M Giovannini, M Ducreux, P Michel, E François, C Lemanski, ... Annals of oncology 12 (3), 397-404, 2001 | 103 | 2001 |
| Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer JE Bibault, B Prevost, E Dansin, X Mirabel, T Lacornerie, E Lartigau Radiation oncology 7, 1-7, 2012 | 100 | 2012 |
| Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy S Dewas, JE Bibault, X Mirabel, I Fumagalli, A Kramar, H Jarraya, ... Radiation Oncology 7, 1-9, 2012 | 92 | 2012 |
| Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102 G Crehange, P Maingon, K Peignaux, TD N′ guyen, X Mirabel, ... Journal of clinical oncology 25 (31), 4895-4901, 2007 | 92 | 2007 |
| Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer D Azria, J Doyen, M Jarlier, I Martel-Lafay, C Hennequin, P Etienne, ... Annals of Oncology 28 (10), 2436-2442, 2017 | 90 | 2017 |
| Ineffectiveness of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer G Piessen, G Petyt, A Duhamel, X Mirabel, D Huglo, C Mariette Annals of surgery 258 (1), 66-76, 2013 | 87 | 2013 |
| Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal … D Peiffert, JF Seitz, P Rougier, E Francois, F Cvitkovic, X Mirabel, S Nasca, ... Annals of oncology 8 (6), 575-581, 1997 | 86 | 1997 |
| Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients E Pape, N Rezvoy, N Penel, J Salleron, V Martinot, P Guerreschi, ... Journal of the American Academy of Dermatology 65 (5), 983-990, 2011 | 79 | 2011 |
Thomas LacornerieMedical Physicist, Centre Oscar LambretAdresse e-mail validée de o-lambret.fr
